FDA Lifts Ban on Indian Firm to Facilitate Hydroxychloroquine, Chloroquine Shipments
The FDA has removed an Indian supplier of hydroxychloroquine and chloroquine APIs from an import alert to free up imports of the potential COVID-19 treatments from two of its plants.
Source: Devices & Diagnostics Letter